TY - JOUR T1 - Simvastatin-Induced Meralgia Paresthetica JF - The Journal of the American Board of Family Medicine JO - J Am Board Fam Med SP - 469 LP - 473 DO - 10.3122/jabfm.2011.04.100229 VL - 24 IS - 4 AU - Sasson Menahem AU - Pesach Shvartzman Y1 - 2011/07/01 UR - http://www.jabfm.org/content/24/4/469.abstract N2 - 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) cause mainly muscular adverse effects. During the last 20 years there has been solid evidence of peripheral neuropathy caused by statins, with a risk of one in 10,000 patients treated for 1 year. Meralgia paresthetica is an entrapment neuropathy occasionally encountered by primary care physicians. To date there has been no report of entrapment neuropathy that could have been caused or aggravated by statins. This case report presents meralgia paresthetica aggravated by simvastatin use that disappeared after simvastatin cessation. ER -